{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:47Z","timestamp":1790015507326,"version":"4.0.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.coi.2008.09.005","type":"journal-article","created":{"date-parts":[[2008,10,18]],"date-time":"2008-10-18T04:54:59Z","timestamp":1224305699000},"page":"709-716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["New concepts in chronic urticaria"],"prefix":"10.1016","volume":"20","author":[{"given":"Becky M","family":"Vonakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarbjit S","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2008.09.005_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib2_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1398-9995.2004.00473.x","article-title":"Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients","volume":"59","author":"Toubi","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib4_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S1081-1206(10)60462-0","article-title":"Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1","volume":"100","author":"Morgan","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib5","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2005.06385.x","article-title":"Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life","volume":"152","author":"Grob","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archdermatol.2007.5","article-title":"Annual direct and indirect costs of chronic idiopathic urticaria: a cost analysis of fifty non-immunocompromised patients","volume":"144","author":"Delong","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0091-6749(95)70055-2","article-title":"Mast cell number and phenotype in chronic idiopathic urticaria","volume":"96","author":"Smith","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0091-6749(92)90297-F","article-title":"Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission","volume":"89","author":"Jacques","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib10","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/0091-6749(86)90377-5","article-title":"Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine","volume":"77","author":"Cohen","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib11_1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1067\/mai.2002.123236","article-title":"TH1\/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction","volume":"109","author":"Ying","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0091-6749(99)70475-6","article-title":"Cutaneous inflammatory cell infiltrate in chronic idiopathic urticaria: comparison of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies","volume":"103","author":"Sabroe","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1034\/j.1600-0625.2003.00010.x","article-title":"Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test","volume":"12","author":"Caproni","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/1523-1747.ep12462239","article-title":"Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes","volume":"90","author":"Gruber","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib15","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJM199306033282204","article-title":"Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria","volume":"328","author":"Hide","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2008.09.005_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1081-1206(10)60588-1","article-title":"Pathophysiology of chronic urticaria","volume":"100","author":"Brodell","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/01.all.0000182540.45348.bc","article-title":"Autoantibodies to the high-affinity IgE receptor in chronic urticaria: how important are they?","volume":"5","author":"Sheikh","year":"2005","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2222.2003.01589.x","article-title":"Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity","volume":"33","author":"Grattan","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.clim.2004.10.007","article-title":"Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals","volume":"114","author":"Caproni","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib20","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-2222.1997.tb02986.x","article-title":"Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity","volume":"27","author":"Grattan","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4049\/jimmunol.146.2.671","article-title":"Prednisone inhibits the appearance of inflammatory mediators and the influx of eosinophils and basophils associated with the cutaneous late-phase response to allergen","volume":"146","author":"Charlesworth","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2222.1974.tb01384.x","article-title":"Serum and cell bound IgE in chronic urticaria","volume":"4","author":"Greaves","year":"1974","journal-title":"Clin Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib23_1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1172\/JCI108405","article-title":"Defective histamine release in chronic urticaria","volume":"57","author":"Kern","year":"1976","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2008.09.005_bib24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0091-6749(98)70283-0","article-title":"Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria","volume":"102","author":"Sabroe","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib25","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2222.2005.02212.x","article-title":"Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli","volume":"35","author":"Luquin","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib26_1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jaci.2006.09.035","article-title":"Basophil FceRI histamine release parallels expression of Src-homology2-containing inositol phosphatases in chronic idiopathic urticaria","volume":"119","author":"Vonakis","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.184.1.71","article-title":"Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells","volume":"184","author":"Zhang","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2008.09.005_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0091-6749(99)70367-2","article-title":"Syk deficiency in nonreleaser basophils","volume":"104","author":"Kepley","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib29","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jaci.2004.08.037","article-title":"Loss of syk kinase during IgE-mediated stimulation of human basophils","volume":"114","author":"Macglashan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib30_1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2006.09.040","article-title":"Relationship between spleen tyrosine kinase and phosphatidylinositol 5\u2032 phosphatase expression and secretion from human basophils in the general population","volume":"119","author":"Macglashan","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib31","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1074\/jbc.R700044200","article-title":"Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes","volume":"283","author":"Harris","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2008.09.005_bib32","doi-asserted-by":"crossref","first-page":"13991","DOI":"10.1074\/jbc.272.21.13991","article-title":"The negative signaling molecule SH2 domain-containing inositol-polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated beta subunit of the high affinity IgE receptor","volume":"272","author":"Kimura","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2008.09.005_bib33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4049\/jimmunol.174.1.507","article-title":"SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels","volume":"174","author":"Gimborn","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib34","doi-asserted-by":"crossref","first-page":"11330","DOI":"10.1073\/pnas.95.19.11330","article-title":"The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation","volume":"95","author":"Huber","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2008.09.005_bib35","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1067\/mai.2001.119159","article-title":"Src homology 2 domain-containing inositol 5\u2032 phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils","volume":"108","author":"Vonakis","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jaci.2006.07.022","article-title":"Initial Fc epsilon RI-mediated signal strength plays a key role in regulating basophil signaling and deactivation","volume":"118","author":"Gibbs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4049\/jimmunol.179.1.95","article-title":"The inositol 5\u2032-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production","volume":"179","author":"Leung","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jaci.2007.10.010","article-title":"Syk-deficient basophils from donors with chronic idiopathic urticaria exhibit a spectrum of releasability","volume":"121","author":"Vonakis","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib39_1","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2008.55","article-title":"Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies","volume":"128","author":"Eckman","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1081-1206(10)60449-8","article-title":"Basophil histamine release activity and disease severity in chronic idiopathic urticaria","volume":"100","author":"Baker","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib41","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2133.2008.08499.x","article-title":"Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus","volume":"158","author":"Lourenco","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib42","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/j.1365-2222.2006.02494.x","article-title":"Evidence of in vivo basophil activation in chronic idiopathic urticaria","volume":"36","author":"Vasagar","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib43","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mai.2002.121314","article-title":"Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria","volume":"109","author":"Confino-Cohen","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000066772","article-title":"Secretion of cytokines, histamine and leukotrienes in chronic urticaria","volume":"129","author":"Ferrer","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib45","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.intimp.2008.05.016","article-title":"Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria","volume":"8","author":"Dos Santos","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.coi.2008.09.005_bib46","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cyto.2004.03.016","article-title":"Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria","volume":"27","author":"Confino-Cohen","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.coi.2008.09.005_bib47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000058004","article-title":"Immune profiles of patients with chronic idiopathic urticaria","volume":"128","author":"Piconi","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib48","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V97.7.2045","article-title":"Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes","volume":"97","author":"Kambe","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.coi.2008.09.005_bib49","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.4049\/jimmunol.179.2.1353","article-title":"Omalizumab reverses the phenotypic and functional effects of IgE-enhanced Fc epsilonRI on human skin mast cells","volume":"179","author":"Gomez","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib50","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2133.1999.02815.x","article-title":"Human leucocyte antigen class II associations in chronic idiopathic urticaria","volume":"140","author":"O\u2019Donnell","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib51","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2133.2006.07183.x","article-title":"Chronic idiopathic urticaria with functional autoantibodies: 12 years on","volume":"154","author":"Sabroe","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib52","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","article-title":"Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies","volume":"40","author":"Sabroe","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2008.09.005_bib53","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1067\/mai.2002.126782","article-title":"Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity","volume":"110","author":"Sabroe","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1398-9995.2005.00673.x","article-title":"The autologous serum skin test in the follow-up of patients with chronic urticaria","volume":"60","author":"Fusari","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib55_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000075251","article-title":"Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test","volume":"133","author":"Mari","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib56","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1468-3083.2006.01852.x","article-title":"The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals","volume":"21","author":"Guttman-Yassky","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2008.09.005_bib57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1067\/mai.2000.108913","article-title":"Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria","volume":"106","author":"Fagiolo","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Grattan","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coi.2008.09.005_bib59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1081-1206(10)60403-6","article-title":"Coagulation cascade and fibrinolysis in patients with multiple-drug allergy syndrome","volume":"100","author":"Asero","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib60","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jaci.2004.12.1120","article-title":"Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria","volume":"115","author":"Soundararajan","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib61","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","article-title":"A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria","volume":"109","author":"Kikuchi","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib62","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1067\/mai.2001.115484","article-title":"Mechanisms of autoimmune activation of basophils in chronic urticaria","volume":"107","author":"Kikuchi","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib63","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2006.02.016","article-title":"Chronic urticaria sera increase basophil CD203c expression","volume":"117","author":"Yasnowsky","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1172\/JCI511","article-title":"Anti-FcepsilonRIalpha autoantibodies in autoimmune-mediated disorders. Identification of a structure\u2013function relationship","volume":"101","author":"Fiebiger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coi.2008.09.005_bib65","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.4049\/jimmunol.175.10.6589","article-title":"A high-affinity natural autoantibody from human cord blood defines a physiologically relevant epitope on the FcepsilonRIalpha","volume":"175","author":"Bobrzynski","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib66_1","first-page":"278","article-title":"Immunomodulatory approaches to the management of chronic urticaria: an immune-mediated inflammatory disease","volume":"8","author":"Bingham Iii CO","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.coi.2008.09.005_bib67","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0952-7915(02)00404-1","article-title":"How IgE upregulates the allergic response","volume":"14","author":"Saini","year":"2002","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib68","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2005.01.040","article-title":"An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment","volume":"115","author":"Meltzer","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab induced reductions in mast cell FceRI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib70","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.4049\/jimmunol.175.7.4167","article-title":"Mast cell survival and activation by IgE in the absence of antigen: a consideration of the biologic mechanisms and relevance","volume":"175","author":"Kawakami","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib71","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.jaci.2007.12.1157","article-title":"Human IgE+ and IgE\u2212 are not equivalent to mouse highly cytokinergic IgE","volume":"121","author":"Xie","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib72","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","article-title":"Effect of omalizumab on patients with chronic urticaria","volume":"99","author":"Spector","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib73_1","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jaci.2007.12.1121","article-title":"Effect of anti-IgE (omalizumab) in chronic idiopathic urticaria patients","volume":"121","author":"Gober","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib74_1","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib75","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2006.05.023","article-title":"Identification of the Syk kinase inhibitor R112 by a human mast cell screen","volume":"118","author":"Rossi","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2008.09.005_bib76","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1182\/blood-2007-03-079699","article-title":"Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells","volume":"110","author":"Ong","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.coi.2008.09.005_bib77","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1586\/14737159.7.5.625","article-title":"Reverse-phase protein microarrays: application to biomarker discovery and translational medicine","volume":"7","author":"VanMeter","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.coi.2008.09.005_bib78","unstructured":"Saini S, Paterniti M, Vasagar K, Gibbons SC Jr., Sterba PM, Vonakis BM, Cultured mast cells from chronic idiopathic urticaria patients spontaneously degranulate upon IgE sensitization: relationship to expression of Syk and SHIP-2, submitted for publication."}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791508001805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791508001805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:22:54Z","timestamp":1760602974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791508001805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0952791508001805"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2008.09.005","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New concepts in chronic urticaria","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2008.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}